In hepatocellular carcinoma, PCSK9 was found to promote cell growth by inhibiting cell apoptosis via the involvement of the Bax/Bcl-2/Caspase-9/Caspase-3 pathway [29]. Here, CASP9 is linked to hepatocellular carcinoma.